APP and Alzheimer disease: The genetic link between amyloidogenic APP processing and AD led to the emergence of the amyloid cascade hypothesis (ACH) [1], which posits that amyloid aggregation and deposition is the triggering event in AD pathogenesis and has led to the development of AD treatments targeting Aβ [2,3,4].